Belief BioMed ("BBM") today announced that BBM-H901 (generic name: Dalnacogene Ponparvovec Injection), has been officially approved by the Pharmaceutical Administration Bureau of Macao Special ...
Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, novel, injectable formulation of nimodipine being ...
TG Therapeutics, Inc. (“TG” or “the Company”), (NASDAQ: TGTX), today announced that it has entered into a new five-year, $750 million senior secured credit facility with funds managed by Blue Owl ...
Pharmacosmos initiates phase III clinical trial of trilaciclib in limited-stage small cell lung cancer MORRISTOWN, NJ, ...
Patients in East Central Indiana facing complex medical conditions like Alzheimer’s, Crohn’s disease, and multiple sclerosis no longer have to travel long distances for specialized care. Hancock ...
Patients in East Central Indiana facing complex medical conditions like Alzheimer’s, Crohn’s disease, and multiple sclerosis no longer have to travel long distances for specialized care.
As NAD+ injections and IV drips trend from TikTok to the Kardashians, the science of longevity remains a work in progress. Explore the benefits, side effects, and the debate between oral precursors ...
Researchers at the Massachusetts Institute of Technology (MIT) have developed a groundbreaking approach to administering therapeutic antibodies that could significantly transform treatment protocols ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results